MCK Stock Overview
Provides healthcare services in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Narratives
BetaNarratives bring a range of perspectives from our community.
Warren
Based on Analyst Price Targets
Price at publication US$523.37
View narrative
Updated
McKesson Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$586.11 |
| 52 Week High | US$587.23 |
| 52 Week Low | US$383.82 |
| Beta | 0.45 |
| 1 Month Change | 7.40% |
| 3 Month Change | 11.13% |
| 1 Year Change | 50.59% |
| 3 Year Change | 199.79% |
| 5 Year Change | 334.67% |
| Change since IPO | 3,452.18% |
Recent News & Updates
Recent updates
With McKesson Corporation (NYSE:MCK) It Looks Like You'll Get What You Pay For
May 09
Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?
Mar 14McKesson: GLP-1 Contributed More Than 1/3 Of Growth
Feb 19McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues
Feb 16Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking
Jan 29McKesson: Why The Company Is Too Richly Valued
Jan 19If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity
Nov 20McKesson: GLP-1 Medications Tailwinds And Massive Share Repurchase
Nov 08Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?
Oct 30McKesson: Still Trading For A Huge Discount
Sep 06Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors
Aug 21Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?
Jul 27McKesson: Outlook Remains Positive, I Reiterate My Buy Recommendation
Jun 28Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors
May 23Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?
Apr 17Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?
Feb 22McKesson Corporation: Looking Forward To Long-Term Low-Teens EPS Growth
Feb 08McKesson Non-GAAP EPS of $6.90 beats by $0.54, revenue of $70.5B misses by $480M
Feb 01McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price
Jan 125 Reasons Why I Am Considering Adding McKesson To My Portfolio
Dec 27McKesson Corporation: Still Trading Below Intrinsic Value
Dec 13Duration: The Time Bomb In Your Portfolio - McKesson And PayPal In Focus
Oct 08McKesson extends distribution partnership with CVS Health
Sep 29An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 50% Undervalued
Sep 19McKesson to acquire Rx Savings Solutions in $875M deal
Sep 19Cardinal Health, McKesson hit 52-week highs; up 35% and 50% YTD
Aug 15McKesson raises fiscal 2023 adjusted diluted EPS following strong quarterly results
Aug 03McKesson raises dividend by 15% to $0.54/share
Jul 25McKesson Is Still An Attractive Dividend Growth Stock
Jul 10McKesson: Best Of Breed In Drug Distributor Oligopoly
Jun 20Shareholder Returns
| MCK | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 4.5% | 3.9% | 1.8% |
| 1Y | 50.6% | 2.6% | 22.8% |
Return vs Industry: MCK exceeded the US Healthcare industry which returned 2.6% over the past year.
Return vs Market: MCK exceeded the US Market which returned 22.8% over the past year.
Price Volatility
| MCK volatility | |
|---|---|
| MCK Average Weekly Movement | 2.2% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: MCK has not had significant price volatility in the past 3 months.
Volatility Over Time: MCK's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1833 | 48,000 | Brian Tyler | www.mckesson.com |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International.
McKesson Corporation Fundamentals Summary
| MCK fundamental statistics | |
|---|---|
| Market cap | US$75.34b |
| Earnings (TTM) | US$3.00b |
| Revenue (TTM) | US$308.95b |
25.4x
P/E Ratio0.2x
P/S RatioIs MCK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MCK income statement (TTM) | |
|---|---|
| Revenue | US$308.95b |
| Cost of Revenue | US$296.37b |
| Gross Profit | US$12.58b |
| Other Expenses | US$9.58b |
| Earnings | US$3.00b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 23.09 |
| Gross Margin | 4.07% |
| Net Profit Margin | 0.97% |
| Debt/Equity Ratio | -342.2% |
How did MCK perform over the long term?
See historical performance and comparison